How much is Tahoe worth in 2026?

Tahoe has a current valuation of $131.0M based on their Early Stage VC round and secondary market data.

How much funding has Tahoe raised?

Tahoe has raised $50.0M in total funding across 1 funding rounds.

Tahoe

Drug DiscoveryWebsite

Tahoe valuation and funding history | Last updated: August 11, 2025 | 1 funding rounds

Current Valuation

$131.0M

As of August 11, 2025

Total Funding Raised

$50.0M

Across 1 round

Last Round

Early Stage VC

$35.0M

Last Funding

Aug 2025

Funding date

Capital Efficiency

2.62x

Valuation / Funding

Funding History & Valuation Timeline

Complete history of all funding rounds and valuation milestones

Date	Round	Amount	Post-Valuation	Growth
August 11, 2025	Early Stage VC (Series A)	$35.0M	N/A	-

Valuation Analysis

Current Valuation Metrics

Tahoe is currently valued at $131.0M as of August 11, 2025. The company has raised a total of $50.0M in funding across 1 funding round.

Capital Efficiency

With a capital efficiency ratio of 2.62x, Tahoe has achieved a valuation that is 2.62 times the total capital raised.

Track Tahoe Valuation Updates

Get notified when Tahoe raises new funding or valuation changes

Explore More Data

Detailed analysis for Tahoe

Secondary Market Price

Real-time pricing data and trends

Valuation Tracker

Historical valuation changes

Funding History

Complete funding round timeline

Secondary Price History

Historical transaction data

All Investors

Complete list of all investors

View 5 companies free

Create a free account to unlock Tahoe's valuation history, funding rounds, and growth metrics.

No credit card required

What is Tahoe Worth in 2026?

Tahoe is a leading private company in the Drug Discovery sector. Track Tahoe's valuation history, funding timeline, and implied market value from secondary transactions on Premier Alternatives.

How Tahoe Valuation is Determined

Private company valuations like Tahoe's are determined through primary funding rounds led by venture capital firms, private equity investors, and strategic partners. The valuation reflects factors including revenue growth, market opportunity, competitive positioning, and investor sentiment.